Literature DB >> 3416116

Growth rate of hepatic metastases in colorectal carcinoma.

I G Finlay1, D Meek, F Brunton, C S McArdle.   

Abstract

The rates of growth of 29 hepatic metastases from 15 patients with primary colorectal carcinoma were studied using serial computed tomography (CT). Eleven metastases were found by the surgeon at laparotomy (overt metastases); the remaining eighteen were not evident to the surgeon at laparotomy, but were detected by CT scan during the immediate postoperative period (occult metastases). An estimate of tumour volume doubling time was obtained from a semi-logarithmic plot of tumour cell number against time. The mean doubling time for the overt metastases was 155 +/- 34 days (+/- s.e.m.) compared with 86 +/- 12 days (P less than 0.05) for the occult metastases. The age of the metastases at the time of surgery was estimated by extrapolation of the observed growth curve assuming Gompertzian kinetics. The mean age of the overt metastases was 3.7 +/- 0.9 years (+/- s.e.m.) The corresponding age of the occult metastases was 2.3 +/- 0.4 years.

Entities:  

Mesh:

Year:  1988        PMID: 3416116     DOI: 10.1002/bjs.1800750707

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  35 in total

Review 1.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

2.  Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

Authors:  Edward Leen; Piercarlo Ceccotti; Susan J Moug; Paul Glen; John MacQuarrie; Wilson J Angerson; Thomas Albrecht; Joachim Hohmann; Anja Oldenburg; Jorg Peter Ritz; Paul G Horgan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Improving survival after large bowel cancer.

Authors:  T G Allen-Mersh
Journal:  BMJ       Date:  1991-09-14

Review 4.  Resection of liver metastases from a colorectal carcinoma does not benefit the patient.

Authors:  T M Hunt; N Carty; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

Review 5.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

Review 6.  Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Authors:  G Scott Gazelle; M G Myriam Hunink; Karen M Kuntz; Pamela M McMahon; Elkan F Halpern; Molly Beinfeld; Jessica S Lester; Kenneth K Tanabe; Milton C Weinstein
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 7.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

8.  [Colorectal cancer metastasis. Frequency, prognosis, and consequences].

Authors:  D Hölzel; R Eckel; J Engel
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

9.  Outcome in colorectal adenocarcinoma: two seven-year studies of a population.

Authors:  N L Gordon; A A Dawson; B Bennett; G Innes; O Eremin; P F Jones
Journal:  BMJ       Date:  1993-09-18

10.  The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study.

Authors:  Jun Won Kim; Yong Bae Kim; Nam-Kyu Kim; Byung-Soh Min; Sang Joon Shin; Joong Bae Ahn; Woong Sub Koom; Jinsil Seong; Ki Chang Keum
Journal:  Radiat Oncol       Date:  2010-08-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.